Catalyst Pharmaceuticals Inc.

NASDAQ: CPRX
Share price (12/31/24): $20.87
Market cap (12/31/24): $2.489 billion

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 09/30/24 Q3

ended 06/30/24 Q2

ended 03/31/24 Q1

ended 12/31/23 FY 2023

ended 09/30/23 Q3

Prospectuses and Registrations Filter

Registration of securities for employees

Additional exhibits for registration

Additional exhibits for registration

Additional exhibits for registration

Prospectus supplement for primary offering

Ownership Filter

Tierney David S

Sundaram Preethi

O'Keeffe Charles B

News Filter

Reports Strong Third Quarter 2024 Financial Results and Provides Corporate Update

Announces Sub-Licensee DyDo Pharma Received Approval to Commercialize FIRDAPSE® in Japan

Reports Strong Second Quarter 2024 Financial Results and Provides Corporate Update

Enters Into an Exclusive License, Supply and Commercialization Agreement With Kye Pharmaceuticals for AGAMREE® in Canada

Receives U.S. FDA Approval for Increased Maximum Daily Dose for FIRDAPSE®

Proxies Filter

Definitive proxy

Definitive proxy

Additional info about upcoming vote

Definitive proxy

Definitive proxy

Other Filter

Letter from the SEC

Correspondence with the SEC

Letter from the SEC

Correspondence with the SEC

Letter from the SEC